Resistin as a Biomarker Linking Obesity and Inflammation to Cancer: Potential Clinical Perspectives
- 11 December 2013
- journal article
- Published by Taylor & Francis in Biomarkers in Medicine
- Vol. 8 (1) , 107-118
Abstract
Excess body weight is associated with various types of malignancies. Resistin, originally described as an adipocyte-specific hormone modulating insulin resistance in rodents, may exhibit proliferative, antiapoptotic, proinflammatory, proangiogenic and metastatic properties. Accumulating evidence supports a role of resistin as a risk factor and potential diagnostic and prognostic biomarker in cancer. In this report, the current knowledge about resistin's properties and pathophysiological implications in cancer in the context of dysregulated adipose tissue in obesity is summarized; clinical translations, preventive and therapeutic considerations, and future perspectives in the field of resistin research are discussed. At the same time, several enigmatic issues involving resistin receptor and signaling pathways remain to be clarified in order to unmask its ontological role in cancer pathophysiology.Keywords
Funding Information
- Research Account of Athens University
This publication has 60 references indexed in Scilit:
- Leptin's Role in Lipodystrophic and Nonlipodystrophic Insulin-Resistant and Diabetic IndividualsEndocrine Reviews, 2013
- Obesity and cancer risk: evidence, mechanisms, and recommendationsAnnals of the New York Academy of Sciences, 2012
- Obesity, metabolic dysregulation, and cancer: a growing concern and an inflammatory (and microenvironmental) issueAnnals of the New York Academy of Sciences, 2012
- The Role of Adiponectin in Cancer: A Review of Current EvidenceEndocrine Reviews, 2012
- Resistin: functional roles and therapeutic considerations for cardiovascular diseaseBritish Journal of Pharmacology, 2012
- The role of resistin as a regulator of inflammation: Implications for various human pathologiesClinical Immunology, 2009
- Adipocyte-specific Expression of Murine Resistin Is Mediated by Synergism between Peroxisome Proliferator-activated Receptor γ and CCAAT/Enhancer-binding ProteinsJournal of Biological Chemistry, 2009
- Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studiesThe Lancet, 2008
- Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatinDiabetologia, 2006
- The hormone resistin links obesity to diabetesNature, 2001